药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Oxybuprocaine
Dexamethasone isonicotinate
Ephedrine may increase the excretion rate of Dexamethasone isonicotinate which could result in a lower serum level and potentially a reduction in efficacy.
Oxybuprocaine
Meprednisone
Ephedrine may increase the excretion rate of Meprednisone which could result in a lower serum level and potentially a reduction in efficacy.
Oxybuprocaine
Fluprednisolone
Ephedrine may increase the excretion rate of Fluprednisolone which could result in a lower serum level and potentially a reduction in efficacy.
Oxybuprocaine
Tixocortol
Ephedrine may increase the excretion rate of Tixocortol which could result in a lower serum level and potentially a reduction in efficacy.
Oxybuprocaine
Fluprednidene
Ephedrine may increase the excretion rate of Fluprednidene which could result in a lower serum level and potentially a reduction in efficacy.
Oxybuprocaine
Fluticasone furoate
Ephedrine may increase the excretion rate of Fluticasone furoate which could result in a lower serum level and potentially a reduction in efficacy.
Oxybuprocaine
Difluprednate
Ephedrine may increase the excretion rate of Difluprednate which could result in a lower serum level and potentially a reduction in efficacy.
Oxybuprocaine
Aldosterone
Ephedrine may increase the excretion rate of Aldosterone which could result in a lower serum level and potentially a reduction in efficacy.
Oxybuprocaine
Ciclesonide
Ephedrine may increase the excretion rate of Ciclesonide which could result in a lower serum level and potentially a reduction in efficacy.
Oxybuprocaine
Paramethasone
Ephedrine may increase the excretion rate of Paramethasone which could result in a lower serum level and potentially a reduction in efficacy.
Oxybuprocaine
Cortisone acetate
Ephedrine may increase the excretion rate of Cortisone acetate which could result in a lower serum level and potentially a reduction in efficacy.
Oxybuprocaine
Corticotropin
Ephedrine may increase the excretion rate of Corticotropin which could result in a lower serum level and potentially a reduction in efficacy.
Oxybuprocaine
Trilostane
Ephedrine may increase the excretion rate of Trilostane which could result in a lower serum level and potentially a reduction in efficacy.
Oxybuprocaine
Rimexolone
Ephedrine may increase the excretion rate of Rimexolone which could result in a lower serum level and potentially a reduction in efficacy.
Oxybuprocaine
Testosterone undecanoate
Testosterone undecanoate may increase the hypertensive activities of Ephedrine.
Oxybuprocaine
Solriamfetol
The risk or severity of hypertension can be increased when Solriamfetol is combined with Ephedrine.
Oxybuprocaine
Esketamine
The risk or severity of hypertension can be increased when Esketamine is combined with Ephedrine.
Oxybuprocaine
Thyrotropin
The risk or severity of adverse effects can be increased when Ephedrine is combined with Thyrotropin.
Oxybuprocaine
Benzylthiouracil
The risk or severity of adverse effects can be increased when Ephedrine is combined with Benzylthiouracil.
Oxybuprocaine
Elcatonin
The risk or severity of adverse effects can be increased when Ephedrine is combined with Elcatonin.